Terms: = Prostate cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Treatment
65 results:
1. First-line Systemic treatment Options for Metastatic Castration-Sensitive prostate cancer: A Living Systematic Review and Network Meta-analysis.
Riaz IB; Naqvi SAA; He H; Asghar N; Siddiqi R; Liu H; Singh P; Childs DS; Ravi P; Hussain SA; Murad MH; Boorjian SA; Sweeney C; Van Allen EM; Bryce AH
JAMA Oncol; 2023 May; 9(5):635-645. PubMed ID: 36862387
[TBL] [Abstract] [Full Text] [Related]
2. Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.
Hemminki K; Försti A; Liska V; Kanerva A; Hemminki O; Hemminki A
Int J Cancer; 2023 May; 152(9):1837-1846. PubMed ID: 36571455
[TBL] [Abstract] [Full Text] [Related]
3. Skene's Gland Malignancy: A Case Report and Systematic Review.
Slopnick EA; Bagby C; Mahran A; Nagel C; Garcia J; El-Nashar S; Hijaz AK
Urology; 2022 Jul; 165():36-43. PubMed ID: 35192863
[TBL] [Abstract] [Full Text] [Related]
4. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Attard G; Murphy L; Clarke NW; Cross W; Jones RJ; Parker CC; Gillessen S; Cook A; Brawley C; Amos CL; Atako N; Pugh C; Buckner M; Chowdhury S; Malik Z; Russell JM; Gilson C; Rush H; Bowen J; Lydon A; Pedley I; O'Sullivan JM; Birtle A; Gale J; Srihari N; Thomas C; Tanguay J; Wagstaff J; Das P; Gray E; Alzoueb M; Parikh O; Robinson A; Syndikus I; Wylie J; Zarkar A; Thalmann G; de Bono JS; Dearnaley DP; Mason MD; Gilbert D; Langley RE; Millman R; Matheson D; Sydes MR; Brown LC; Parmar MKB; James ND;
Lancet; 2022 Jan; 399(10323):447-460. PubMed ID: 34953525
[TBL] [Abstract] [Full Text] [Related]
5. Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis.
Gaudino M; Hameed I; Farkouh ME; Rahouma M; Naik A; Robinson NB; Ruan Y; Demetres M; Biondi-Zoccai G; Angiolillo DJ; Bagiella E; Charlson ME; Benedetto U; Ruel M; Taggart DP; Girardi LN; Bhatt DL; Fremes SE
JAMA Intern Med; 2020 Dec; 180(12):1638-1646. PubMed ID: 33044497
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract] [Full Text] [Related]
7. Regulation of eif4f Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant prostate cancer.
Garrido MF; Martin NJ; Bertrand M; Gaudin C; Commo F; El Kalaany N; Al Nakouzi N; Fazli L; Del Nery E; Camonis J; Perez F; Lerondel S; Le Pape A; Compagno D; Gleave M; Loriot Y; Désaubry L; Vagner S; Fizazi K; Chauchereau A
Clin Cancer Res; 2019 Jan; 25(2):710-723. PubMed ID: 30322877
[TBL] [Abstract] [Full Text] [Related]
8. Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during prostate cancer progression and modulates cell growth and metastasis.
Jaiswal PK; Koul S; Shanmugam PST; Koul HK
Sci Rep; 2018 May; 8(1):7459. PubMed ID: 29748619
[TBL] [Abstract] [Full Text] [Related]
9. A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in prostate cancer Patients Prior to Radical prostatectomy.
Sayyid RK; Evans A; Hersey K; Maloni R; Hurtado-Coll A; Kulkarni G; Finelli A; Zlotta AR; Hamilton R; Gleave M; Fleshner NE
Clin Cancer Res; 2017 Apr; 23(8):1974-1980. PubMed ID: 27756786
[No Abstract] [Full Text] [Related]
10. [THE EVOLUTION OF MARKERS OF prostate cancer].
Peshkov MN; Generozov EV; Kostryukova ES
Klin Lab Diagn; 2016 Mar; 61(3):132-40. PubMed ID: 27506103
[TBL] [Abstract] [Full Text] [Related]
11. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.
Ramsay CR; Adewuyi TE; Gray J; Hislop J; Shirley MD; Jayakody S; MacLennan G; Fraser C; MacLennan S; Brazzelli M; N'Dow J; Pickard R; Robertson C; Rothnie K; Rushton SP; Vale L; Lam TB
Health Technol Assess; 2015 Jul; 19(49):1-490. PubMed ID: 26140518
[TBL] [Abstract] [Full Text] [Related]
12. Reiki for depression and anxiety.
Joyce J; Herbison GP
Cochrane Database Syst Rev; 2015 Apr; (4):CD006833. PubMed ID: 25835541
[TBL] [Abstract] [Full Text] [Related]
13. Anaesthetic techniques for risk of malignant tumour recurrence.
Cakmakkaya OS; Kolodzie K; Apfel CC; Pace NL
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008877. PubMed ID: 25379840
[TBL] [Abstract] [Full Text] [Related]
14. Role of 5α-reductase inhibitors in androgen-stimulated skin disorders.
Azzouni F; Zeitouni N; Mohler J
J Drugs Dermatol; 2013 Feb; 12(2):e30-5. PubMed ID: 23377402
[TBL] [Abstract] [Full Text] [Related]
15. Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram.
Kutikov A; Cooperberg MR; Paciorek AT; Uzzo RG; Carroll PR; Boorjian SA
Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):374-9. PubMed ID: 22710832
[TBL] [Abstract] [Full Text] [Related]
16. Role of 5α-reductase inhibitors in benign prostatic diseases.
Azzouni F; Mohler J
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):222-30. PubMed ID: 22333687
[TBL] [Abstract] [Full Text] [Related]
17. Pentamidine reduces expression of hypoxia-inducible factor-1α in DU145 and MDA-MB-231 cancer cells.
Jung HJ; Suh SI; Suh MH; Baek WK; Park JW
Cancer Lett; 2011 Apr; 303(1):39-46. PubMed ID: 21316841
[TBL] [Abstract] [Full Text] [Related]
18. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.
Peeters A; Grutters JP; Pijls-Johannesma M; Reimoser S; De Ruysscher D; Severens JL; Joore MA; Lambin P
Radiother Oncol; 2010 Apr; 95(1):45-53. PubMed ID: 20106540
[TBL] [Abstract] [Full Text] [Related]
19. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
[TBL] [Abstract] [Full Text] [Related]
20. cancer incidence in the wastewater treatment plant of a large chemical company.
Nasterlack M; Messerer P; Pallapies D; Ott MG; Zober A
Int Arch Occup Environ Health; 2009 Jul; 82(7):851-6. PubMed ID: 19190931
[TBL] [Abstract] [Full Text] [Related]
[Next]
